Marisa Rosso

3PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 25, 2026
Aprepitant increases the antitumor activity of chemotherapy by chemosensitizing breast cancer cells.

Prema Robinson, Marisa Rosso, Yousef Zamil

|Feb 13, 2025
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma.

Miguel Muñoz, Marisa Rosso

|Apr 18, 2022
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.

Mario F Muñoz, Sandro Argüelles, Marisa Rosso

Pageof 1

Frequent Collaborators

3 joint publications

Miguel Muñoz

1 joint publications

Mario F Muñoz

1 joint publications

Sandro Argüelles

1 joint publications

Rafael Medina